Aug 06, 2019 / 03:00PM GMT
Operator
Good day, ladies and gentleman and welcome to the Evofem Biosciences' Second Quarter 2019 Results Call.
(Operator Instructions)
I would now like to turn the call over to Amy Raskopf. You may begin.
Amy Raskopf - Evofem Biosciences, Inc. - Investor Relations
Thanks, [Michelle]. Thank you all for participating in today's call. This is Amy Raskopf, Investor Relations for Evofem Biosciences. Please note that the press release we issued yesterday after market and the presentation that accompanies this call are available in the investors section of the Evofem website at evofem.com.
With me today from the Evofem executive team are Chief Executive Officer, Saundra Pelletier; Chief Financial Officer, Jay File; Chief Medical Officer, Kelly Culwell; and Chief Commercial Officer, Russ Barrans.
As noted on slide two, I want to highlight that during this call the Evofem team will make forward-looking statements regarding the company's future expectations, plans, and prospects that constitute forward-looking statements for the purposes of
Q2 2019 Evofem Biosciences Inc Earnings Call Transcript
Aug 06, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers